Analysis of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and its phase I and phase II metabolites in mouse urine using LC-UV-MS-MS

S.F. Teunissen, H. Rosing, L. Brunsveld, T.F.A. Greef, de, S. Durmus, J.H.M. Schellens, A.H. Schinkel, J.H. Beijnen

Onderzoeksoutput: Bijdrage aan tijdschriftTijdschriftartikelAcademicpeer review

3 Citaten (Scopus)
1 Downloads (Pure)

Samenvatting

Over the last two decades, various studies have shown that moderate and persistent hyperhomocysteinemia is implicated in the development of atherosclerosis, which is responsible for 50% of all mortality and morbidity in Western countries. Considering that the most traditional risk factors for heart disease and stroke, such as plasma lipids, cigarette smoking, hypertension, obesity, and diabetes, only account for 50% of cardiovascular disease (1,2), one can understand the reason why homocysteine (Hcy) measurement is included in he list of tests for investigating the causes of atherosclerosis and thrombosis.
Originele taal-2Engels
Pagina's (van-tot)215-226
TijdschriftChromatographia
Volume74
Nummer van het tijdschrift3-4
DOI's
StatusGepubliceerd - 2011

Vingerafdruk Duik in de onderzoeksthema's van 'Analysis of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and its phase I and phase II metabolites in mouse urine using LC-UV-MS-MS'. Samen vormen ze een unieke vingerafdruk.

Citeer dit